Articles with "cd105" as a keyword



Photo from wikipedia

Identification of CD105 (endoglin) as novel risk marker in CLL

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of Hematology"

DOI: 10.1007/s00277-022-04756-4

Abstract: Several genetic and clinical markers are established as prognostic factors in chronic lymphocytic leukemia (CLL). However, additional markers are needed for risk stratification. Flow cytometric analysis is a mainstay of CLL diagnostics, thus identification of… read more here.

Keywords: risk; expression; cll; cd105 ... See more keywords
Photo from wikipedia

CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation

Sign Up to like & get
recommendations!
Published in 2020 at "International Journal of Hematology"

DOI: 10.1007/s12185-020-02875-0

Abstract: Several genetic and molecular markers are general predictors of outcome in acute myeloid leukemia (AML), but only few are predictive of outcomes after allogeneic hematopoietic stem cell transplantation (HSCT). Novel markers are needed to improve… read more here.

Keywords: stem cell; transplantation; expression; cd105 ... See more keywords
Photo from wikipedia

Human umbilical cord mesenchymal stem cells regulate CD54 and CD105 in vascular endothelial cells and suppress inflammation in Kawasaki disease.

Sign Up to like & get
recommendations!
Published in 2021 at "Experimental cell research"

DOI: 10.1016/j.yexcr.2021.112941

Abstract: OBJECTIVE The objective was to evaluate the expression levels of CD31+CD54+ and CD31+CD105+ endothelial microparticles (EMPs) before and after intravenous immunoglobulin (IVIG) treatment of Kawasaki disease (KD). To explore the role of human umbilical cord… read more here.

Keywords: inflammation; expression; endothelial cells; cd105 ... See more keywords
Photo by geraninmo from unsplash

CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model

Sign Up to like & get
recommendations!
Published in 2017 at "PLoS ONE"

DOI: 10.1371/journal.pone.0188072

Abstract: Mesenchymal stem cells are being the focus of connective tissue technology and regenerative medicine, presenting a good choice cell source for improving old and well recognized techniques of cartilage defect repair. For instance, the autologous… read more here.

Keywords: medicine; animal model; mscs; cd105 ... See more keywords
Photo from wikipedia

Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.

Sign Up to like & get
recommendations!
Published in 2019 at "Endocrine-related cancer"

DOI: 10.1530/erc-19-0370

Abstract: While the overall five-year survival rate for prostate cancer is near 100%, up to 35% of patients will develop recurrent disease. At the time of prostatectomy, prostate specific antigen (PSA) is used to guide primary… read more here.

Keywords: cd105; recurrence; cancer; cancer patients ... See more keywords
Photo by nci from unsplash

CD105 (Endoglin): A Potential Anticancer Therapeutic Inhibits Mitogenesis and Map Kinase Pathway Activation

Sign Up to like & get
recommendations!
Published in 2021 at "AntiCancer Research"

DOI: 10.21873/anticanres.14879

Abstract: Background: CD105 is highly expressed on human activated endothelial cells (ECs), is an important component of the TGF-β1 receptor complex and is essential for angiogenesis. CD105 expression is up-regulated in activated ECs and is an… read more here.

Keywords: tgf; cd105 transfectants; cd105 endoglin; cd105 ... See more keywords
Photo from wikipedia

Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.1038807

Abstract: Targeting tumor-associated angiogenesis is currently at the forefront of renal cell carcinoma (RCC) therapy, with sunitinib and bevacizumab leading to increased survival in patients with metastatic RCC (mRCC). However, resistance often occurs shortly after initiation… read more here.

Keywords: renal cell; rcc; cd105; efficacy ... See more keywords
Photo by ospanali from unsplash

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.910196

Abstract: Introduction CD105 is an angiogenic biomarker that is useful to determine the microvessel density (MVD) within a tumor, namely, in highly vascularized tumors like glioblastoma (GBM). However, its expression has shown inconsistent associations with the… read more here.

Keywords: cd105; expression; mvd cd105; gbm patients ... See more keywords